remacemide has been researched along with Absence Seizure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehrer, A; Nehlig, A | 1 |
| Lovic, OS; Susic, V; Zivanovic, D | 1 |
| Borowicz, KK; Czuczwar, SJ; Luszczki, JJ; Malek, R; Patsalos, PN; Ratnaraj, N | 1 |
| Freedman, L; Hudzik, TJ; Palmer, GC | 1 |
| Davies, JA | 1 |
| Eisman, MS; Fedorchuk, M; Garske, GE; Griffith, RC; Murray, RJ; Napier, JJ; Palmer, GC; Ray, RK; Stagnitto, ML; Wilson, TC | 1 |
| Blosser, JC; Freedman, LR; Garske, GE; Griffith, RC; Harris, EW; McCreedy, SA; Napier, JJ; Palmer, GC; Ray, R; Woodhead, JH | 1 |
| Garske, GE; Griffith, RC; Harris, EW; Napier, JJ; Palmer, GC; Stagnitto, ML; Swinyard, EA | 1 |
2 review(s) available for remacemide and Absence Seizure
| Article | Year |
|---|---|
Remacemide hydrochloride: a novel antiepileptic agent.
Topics: Acetamides; Animals; Anticonvulsants; Biotransformation; Epilepsy; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Seizures | 1997 |
Status of PR 934-423, a novel anticonvulsant targeted for generalized tonic/clonic seizures (new designation is FPL 12924AA).
Topics: Acetamides; Animals; Anticonvulsants; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains; Seizures | 1990 |
6 other study(ies) available for remacemide and Absence Seizure
| Article | Year |
|---|---|
Effects of remacemide in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.
Topics: Acetamides; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Male; Rats; Rats, Mutant Strains; Rats, Wistar; Seizures | 2003 |
Effects of manipulation of N-methyl-D-aspartate receptors on imipenem/cilastatin-induced seizures in rats.
Topics: Acetamides; Animals; Binding Sites; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Electroencephalography; Imipenem; Male; Pyrrolidinones; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures; Valine | 2004 |
Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
Topics: Acetamides; Algorithms; Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Electroshock; Epilepsy; Epilepsy, Tonic-Clonic; Male; Memory; Mice; Motor Skills; Phenobarbital; Phenytoin; Seizures; Valproic Acid | 2007 |
Remacemide hydrochloride and ARL 15896AR lack abuse potential: additional differences from other uncompetitive NMDA antagonists.
Topics: Acetamides; Administration, Oral; Animals; Anticonvulsants; Behavior, Animal; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Electroshock; Humans; Injections, Intravenous; Male; Phencyclidine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reinforcement Schedule; Seizures; Self Administration; Stereotyped Behavior; Substance-Related Disorders | 1996 |
Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide.
Topics: Acetamides; Animals; Anticonvulsants; Dizocilpine Maleate; Electroshock; Kindling, Neurologic; Male; Mice; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Seizures | 1992 |
Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat.
Topics: Acetamides; Analysis of Variance; Animals; Anticonvulsants; Drug Tolerance; Electroshock; Kindling, Neurologic; Motor Activity; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Seizures; Stereoisomerism | 1991 |